PWM
ENTX icon

Perigon Wealth Management’s Entera Bio ENTX Stock Holding History

Perigon Wealth Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-145,843
Closed -$248K – 1072
2025
Q1 		$248K Hold
145,843
– – 0.01% 884
2024
Q4 		$325K Buy
+145,843
New +$272K 0.01% 787

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Perigon Wealth Management's ENTX Position: Q2 2025 in Review

Perigon Wealth Management sold out of Entera Bio (ENTX) in Q2 2025, closing a stake of 145,843 shares — an estimated $248K sold.

Perigon Wealth Management first reported a position in ENTX in Q4 2024 and held it in 2 quarters. The position peaked at $325K in Q4 2024. 19 funds tracked by Wall St. Rank hold ENTX as of Q2 2025.

  • Perigon Wealth Management reported no remaining Entera Bio position as of Q2 2025 after selling out during the quarter.
  • Perigon Wealth Management sold 145,843 Entera Bio shares in Q2 2025, an estimated $248K.
  • Perigon Wealth Management first reported a position in Entera Bio in Q4 2024 and held it in 2 quarters.
  • Perigon Wealth Management's Entera Bio position peaked at $325K in Q4 2024.
  • 19 funds tracked by Wall St. Rank held Entera Bio as of Q2 2025.

Based on Perigon Wealth Management's 13F filing for Q2 2025, filed 16 Jul 2025.